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Virulence evolutionWithin-host competition among parasite genotypes affects epidemiology as well as the evolution of vir-
ulence. In the rodent malaria Plasmodium chabaudi, competition among genotypes, as well as clone-spe-
ciﬁc and clone-transcending immunity are well documented. However, variation among genotypes in the
induction of antibodies is not well understood, despite the important role of antibodies in the clearance of
malaria infection. Here, we quantify the potential for antibodies induced by one clone to bind another
(i.e., to cause antibody-mediated apparent competition) for nine genetically distinct P. chabaudi clones.
We hypothesised that clones would vary in the strength of antibody induction, and that the propensity
for clone-transcending immunity between a pair of clones would increase with increasing genetic relat-
edness at key antigenic loci. Using serum collected from mice 35 days post-infection, we measured titres
of antibody to an unrelated antigen, Keyhole Limpet Haemocyanin (KLH), and two malaria antigens:
recombinant Apical Membrane Antigen-1 (AMA-1) and Merozoite Surface Protein-119 (MSP-119). Amino
acid sequence homology within each antigenic locus was used as a measure of relatedness. We found sig-
niﬁcant parasite genetic variation for the strength of antibody induction. We also found that relatedness
at MSP-119 but not AMA-1 predicted clone-transcending binding. Our results help explain the outcome of
chronic-phase mixed infections and generate testable predictions about the pairwise competitive ability
of P. chabaudi clones.
 2013 The Authors. Published by Elsevier B.V.   Open access under CC BY license.1. Introduction malaria parasite Plasmodium chabaudi has been used to investigateIntraspeciﬁc competition among parasites in mixed-genotype
infections is expected to affect the evolution of parasite traits and
of virulence (degree of harm done to hosts) (Mideo, 2009). Such
within-host competition has been demonstrated in a wide range
of parasite taxa (e.g., (Balmer et al., 2009; Bashey et al., 2013; Hall
and Little, 2013)) and can affect establishment of infection and
transmission from the host (Karvonen et al., 2011), the virulence
of infection (Balmer et al., 2009) and parasite population structure
(Gold et al., 2009). Natural malaria infections often comprise more
than one genotype per species (Babiker et al., 1994; Mobegi et al.,
2012; Read and Taylor, 2001; Vardo and Schall, 2007). The rodentthe ecological mechanisms of within-host competition (Bell et al.,
2006; de Roode et al., 2005a,b; De Roode et al., 2003; Taylor et al.,
1997). For example, direct competition for red blood cells (RBCs)
is paramount during the acute phase of infection where parasite
population growth is exponential (De Roode et al., 2003). However,
parasite dynamics during mixed infection are not always easily ex-
plained by resource (exploitation) competition, particularly during
the chronic phase (e.g., (Bell et al., 2006; Mideo et al., 2008)).
Instead, immune-mediated apparent competition (where one
genotype induces an immune response capable of targeting other
genotypes; e.g., (Jarra and Brown, 1985)) or facilitation (if one geno-
type distracts immunological attention from others) may deter-
mine the outcome of within-host competition (Barclay et al.,
2008; Raberg et al., 2006). Importantly, the direction of natural
selection on parasite virulence depends upon the mechanism of
competition (Mideo, 2009).
Malaria poses a particularly interesting system for considering
immune-mediated apparent competition and facilitation, because
mammalian adaptive immunity is capable of exquisite speciﬁcity
to malaria antigens (Couper et al., 2005; Quin and Langhorne,
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Brown, 1985, 1989; Martinelli et al., 2005; Pattaradilokrat et al.,
2007), yet the parasites also induce cross-reactive antibodies
through polyclonal expansion of B-cells. This proliferation and
differentiation of B-cells regardless of their antigen-speciﬁcity
(Montes et al., 2007) is attributed to disruption of spleen architec-
ture, innate activation of B-cells, and induction of cytokine storms
(Achtman et al., 2003; Castillo-Mendez et al., 2007; Muxel et al.,
2011). Indeed, induction of cross-reactive immune responses
may be a parasite strategy to promote the chronicity of infection
(Recker et al., 2004). Although variation among P. chabaudi clones
in innate immune response induction has been described (Long
et al., 2006, 2008), and immunocompromised mice (lacking all
T-cells or CD4+ T-helper cells) have been used to test
whether the adaptive immune response inﬂuences competition
between P. chabaudi clones (Barclay et al., 2008; Raberg et al.,
2006), the potential for cross-reactive antibodies to mediate
competition among a wide range of P. chabaudi clones has not been
assessed.
In this study, we measured variation among nine clones in the
induction of cytophilic antibodies, which exhibit a range of speci-
ﬁcities and have great functional importance in the system: they
block parasite invasion and development within RBC, bind infected
RBC (Cavinato et al., 2001) to facilitate uptake and destruction by
phagocytes (Mota et al., 1998), interfere with merozoite dispersal
following RBC rupture (Bergmann-Leitner et al., 2009, 2006; Li
et al., 2001), and are ultimately required for resolution of P. chab-
audi infection (von der Weid et al., 1996). To study potential vari-
ation in polyclonal stimulation of B-cells by the malaria clones, we
measured antibodies binding to the ‘‘exoantigen’’ Keyhole Limpet
Haemocyanin, or KLH, a large and antigenically complex molecule
(Harris and Markl, 1999) that the animals never experienced
in vivo and is often used to quantify variation in antigen-indepen-
dent humoral immune potency (e.g., (Star et al., 2007)). To study
the induction of clone-transcending antibody, we measured bind-
ing of antibodies to two recombinant malaria antigens, Apical
Membrane Antigen-1 (AMA-1) and Merozoite Surface Protein-119
(MSP-119). These antigens are both malaria vaccine candidates
(Anders et al., 1998; Burns et al., 2004; Crewther et al., 1996; Do-
doo et al., 2008; Hensmann et al., 2004) that are known to be poly-
morphic in P. chabaudi (Cheesman et al., 2009; Crewther et al.,
1996; McKean et al., 1993). We expected that these polymor-
phisms may directly predict the ability of antibodies induced by
one clone to bind other clones. Together, our measurements of
general immune potency and binding capacity for malaria antigens
aid prediction of the mode and strength of immune-mediated com-
petition among clones.2. Materials and methods
2.1. Experimental infections
P. chabaudi clones were originally isolated from thicket rats
(Thamnomys rutilans) and cloned by serial dilution and passage
(Beale et al., 1978). These clones were stored as cryopreserved
blood stabilates and passaged through donor mice prior to experi-
mental infection. The clones we used vary in growth rate and vir-
ulence (Long et al., 2008; Mackinnon and Read, 1999) and are
listed here in order of ascending maximum parasitaemia (percent-
age of RBCs infected) achieved in our experiments: AS11943, CW175,
DK116, DS1671, AT53, ER494, AJ4787, CR518, AQ218, (subscript denotes
the point in the lineage from which each clone originates; hereaf-
ter clones are identiﬁed by their two-letter codes, AS, CW, etc.). All
the clones used were P. chabaudi chabaudi except for DS and DK
which belong to the subspecies P. chabaudi adami.Female C57/BL6 mice (Harlan UK), 16–18 weeks of age, were
housed in a 12 h:12 h light–dark cycle, and 41B diet (Harlan UK)
and drinking water supplemented with 0.05% para-amino benzoic
acid (PABA) were provided ad libitum (Jacobs, 1964). For each
clone, we established infections by intraperitoneal injection of
1  105 P. chabaudi parasitised red blood cells (pRBCs). We used
5 experimental mice per clone, except for AS where 6 mice were
used. Parasitaemia was monitored daily by 1000 microscopy of
thin tail-blood smears stained with Giemsa, as described previ-
ously (Mackinnon and Read, 1999). Mice were exsanguinated, un-
der terminal anaesthesia, in the early chronic phase of infection
(day 35 post-infection). This timepoint was at least 3 weeks after
the resolution of acute infection (the primary peak in parasitaemia)
and is expected to reﬂect maximum antibody production (Quin
and Langhorne, 2001), though measurable responses persist for
over 6 months (Achtman et al., 2007). Serum was separated using
SeraSieve (Hughes and Hughes Ltd) by centrifugation at
13,000 rpm for 10 min and stored at 80 C. Protocols for this ani-
mal work were approved by the UK Home Ofﬁce.
2.2. Antigens and antibody measurement
Three proteins were used in this study: Keyhole Limpet Haem-
ocyanin, or KLH (SIGMA) and two recombinant malaria antigens;
Merozoite Surface Protein-119 (MSP-119) and Apical Membrane
Antigen-1 (AMA-1). MSP-119 was originally sequenced from P.
chabaudi chabaudi clone AS and inserted into Pichia pastoris vector
pIC9K for expression in P. pastoris strain SMD1169 as described
previously (Hensmann et al., 2004). Apical Membrane Antigen-1
(AMA-1) was originally sequenced, cloned and expressed from P.
chabaudi adami clone DK. The AMA-1 nucleotide sequence was in-
serted into Escherichia coli vector PQE9 and expressed in the cell
line SG13009 (Crewther et al., 1996).
We used Enzyme Linked Immunosorbent Assays (ELISA) to
measure antigen binding of serum immunoglobulin (Ig) isotypes
IgG1, IgG2a, IgG2b and IgG3 as described previously (Fairlie-Clarke
et al., 2010), with the following adjustments. Serum samples were
added in a series of doubling dilutions (1/100 to 1/204800) using
TBST as diluent. Antibodies that bound antigen were detected with
isotype-speciﬁc hrp-conjugated goat anti-mouse antibodies
(Southern Biotech: IgG1 1070-05 at 1/6000 dilution, IgG2a 1080-
05 at 1/200, IgG2b 1090-05 at 1/4000 and IgG3 1100-05 at 1/
1000). Antibody titres were calculated as the reciprocal of the
greatest dilution at which the O.D. was greater than the mean plus
2 standard deviations of the O.D values for uninfected control sam-
ples binding that antigen at 1/100 dilution. Although all four iso-
types were measured results are only presented for the most
functionally relevant IgG2a.
2.3. Sequencing and bioinformatics
For each clone, when a suitable level of parasitaemia (minimum
5% parasitised RBCs) was observed in the donor mice, we collected
10 ll of whole blood from the tail in an excess of citrate saline
(500 ll) and centrifuged at 13000 rpm for 5 min. The resulting pel-
let was stored at 80 C. We extracted genomic DNA using the
Instagene DNA preparation kit for whole blood (BIO-RAD Cat no.
7326211) according to the manufacturer’s instructions. Polymer-
ase Chain Reaction (PCR) was used to amplify fragments of msp-1
and ama-1, as follows. 8 ll of 1/100 dilution of genomic DNA
was used as a template in a 20 ll PCR reaction in combination with
0.1 mM ﬁnal concentration of the forward and reverse primers.
Primers were designed to amplify a 350 base pair fragment of
msp-1 and a 205 base pair fragment of ama-1. The region of
MSP-119 ampliﬁed for the 9 clones was aligned with the AS
sequence for msp-119, GenBank accession number L22982.1
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Genbank accession number U49745 (nucleotide 137–342).
A Taq enzyme High Fidelity PCR Master kit (Roche) was used for
ampliﬁcation of genomic DNA with the programmed temperature
proﬁle (95 C, 1 min; 35 cycles of 94 C, 45 s; 55 C, 45 s; 68 C,
3 min; 72 C, 5 min). PCR ampliﬁcation products were detected
via 1% agarose gel electrophoresis. Double stranded DNA (dsDNA)
was puriﬁed directly from the PCR reaction using QIAquick PCR
puriﬁcation Kit (Qiagen) according to the manufacturer’s protocol.
A Prism BigDye Terminator and Cycle Sequence Kit Version 3.1
(ABI) were used for the sequencing reaction with 10 ng/ll of
dsDNA and 3.2 pmol/ll ﬁnal concentration of the appropriate pri-
mer. The University of Edinburgh School of Biological Sciences
Sequencing Service ran the products on an ABI 3730 capillary se-
quencer. The resulting nucleotide sequences were aligned using
MacVector 7.2.3 to determine the percentage amino acid identity,
for AMA-1 or MSP-119, amongst the 9 P. chabaudi clones. Our order
of genetic relatedness for MSP-119 based on amino acid sequence
homology is largely in agreement with the genetic relatedness pre-
dicted by the maximum likelihood phylogenetic tree, generated
from a broader analysis of nucleotide diversity in the msp-1 gene
(Cheesman et al., 2009).2.4. Statistical analysis
The serial dilution of serum to calculate antibody titre produces
ordinal data, which were log10 transformed to normalize for linear
modelling (Grafen and Hails, 2007). All analyses were carried out
using statistical package JMP 10 (SAS). General linear statistical
models allowed us to test whether differences in clone identity,
parasitaemia, and/or amino acid homology to the recombinant
antigens best explained the variation in antibody induction. Clone
was included as a ﬁxed factor and its ability to predict antibody ti-
tre was formally evaluated with maximum parasitaemia (Max%P)
as a covariate, plus an interaction term. Models were minimised
as described previously (Fairlie-Clarke et al., 2010). When clone
was a signiﬁcant predictor, all pair-wise Tukey post-hoc tests were
carried out to identify pairs of clones that generated signiﬁcantly
different antibody titres. Finally, Ordered Heterogeneity (OH) anal-
ysis (Gaines and Rice, 1994) allowed a test of the directional
hypothesis that clones which were more homologous (in terms
of amino acid sequence) to the source clone for a recombinant anti-
gen would exhibit higher antibody titres to that antigen. The or-
dered heterogeneity test statistic rsPc, was calculated according
to the equation rsPc = r  (1  P), where r is the Spearman’s rank
correlation coefﬁcient describing the relationship between mean
antibody titres and percentage amino acid identity of clones. P is
the P-value from the analysis of titre with amino acid identity as
the predictor variable. The P-value for the ordered heterogeneity
test statistic (rsPc) was then calculated by reference to the critical
values table in Gaines and Rice (1994). For all tests, cut off for sta-
tistical signiﬁcance was taken as P < 0.05, and reported F statistics
and P-values are from the minimal model.Fig. 1. Maximum percentage of red blood cells infected (i.e., parasitaemia) achieved
by distinct P. chabaudi clones. Figure shows mean and standard error of n = 5–6
infected mice per clone. Groups not connected by the same letter denote pairs that
are signiﬁcantly different (P < 0.05) according to Tukey’s Pairwise analysis.3. Results and discussion
Our results demonstrate variation amongst P. chabaudi clones in
induction of cytophilic antibody and generate predictions about
the likelihood of immune-mediated competition among pairs.
Whilst natural Plasmodium infections may comprise many geno-
types, it is common for two genotypes per host to be observed
(e.g., (Anderson et al., 2000; Auburn et al., 2012; Manske et al.,
2012; Vardo and Schall, 2007)); furthermore, investigating the po-
tential for immune-mediated interactions to occur between pairs
of clones represents a tractable ﬁrst step to studying more complexmixed-genotype infections. We deliberately chose to measure anti-
bodies induced during single-clone infections as this permits
exploration of the potential for apparent competition without the
complications of a mixed-clone setting.
Conﬁrming previous reports on the malaria genotypes used in
this study (e.g., (Long et al., 2008; Mackinnon and Read, 1999)),
clones varied signiﬁcantly in maximum parasitaemia achieved
(Fig. 1; F8,37 = 8.06; P < 0.0001). Clones also varied in polyclonal
B-cell induction, as measured by binding to the exoantigen KLH
(Fig. 2; F8,28 = 2.37; P = 0.044), and with differential dependence
upon parasitaemia (F1,28 = 0.03; P = 0.86 for parasitaemia main ef-
fect; F8,28 = 2.29; P = 0.05 for the clone  parasitaemia interaction).
This suggests signiﬁcant variation among clones in their immune
potency, or their propensity to non-speciﬁcally stimulate a humor-
al response. The acute phase of malaria infection is characterised
by polyclonal B-cell activation (Castillo-Mendez et al., 2007) and
therefore the production of antibodies of a wide array of speciﬁci-
ties, including highly cross-reactive natural antibodies (Ternynck
et al., 1991) and auto antibodies (D’Imperio Lima et al., 1996; Yaffe,
2001), though this is the ﬁrst evidence of parasite genetic variation
in their induction. The role of such natural antibodies in parasite
control has not been deﬁnitively determined but it is possible that
they could interact with conserved parasite antigens (Castillo-
Mendez et al., 2007). Greater immune potency of one clone may
therefore be associated with an increased likelihood of a clone-
transcending response against other clones.
We next assessed whether antibody binding to recombinant
malaria antigens was explained by malaria genotype, parasitaemia,
and/or amino acid sequence homology at antigenic loci. Binding of
cytophilic IgG2a antibody to DK-clone’s AMA-1 (DK-AMA-1) varied
signiﬁcantly amongst clones, largely driven by differences between
AS and ER but not by differences from DK (Fig. 3, with clones
shown in order of decreasing relatedness to the antigenic source
clone, DK; F8,37 = 3.41; P = 0.0049). However, neither parasitaemia
nor genetic relatedness to DK at the ama-1 locus were predictive
of IgG2a titre (P = 0.87 and 0.9, respectively). By contrast, clones in-
duced antibodies capable of binding to MSP-119 in accordance with
their amino acid homology to the recombinant antigen. Binding of
IgG2a to AS-clone’s MSP-119 (AS-MSP-119) varied signiﬁcantly
amongst clones (F8,37 = 12.41; P < 0.0001), generally in accordance
with genetic relatedness at the msp-1 locus (rsPc = 0.67, P = 0.01)
(Fig. 4, with clones shown in order of decreasing relatedness to
the antigenic source clone, AS) but exhibited no relationship with
parasitaemia (P = 0.26). These ﬁndings suggest that when MSP-
119 is the target of immune recognition, the ability of host antibod-
ies to bind AS parasites can be predicted by amino acid sequence
homology. This was not so for AMA-1. This discrepancy may reﬂect
Fig. 2. IgG2a antibody response to exoantigen KLH. Antibody titre was calculated as
the reciprocal of the greatest dilution at which O.D was greater than the mean plus
2 standard deviations of the O.D for control mouse sera at 1/100 dilution.
Figure shows mean and standard error of n = 5–6 infected mice per clone. Groups
not connected by the same letter denote pairs that are signiﬁcantly different
(p < 0.05) according to Tukey’s Pairwise analysis.
Fig. 3. IgG2a antibody response to recombinant AMA-1 antigen from clone DK.
Antibody titre was calculated as the reciprocal of the greatest dilution at which O.D
was greater than the mean plus 2 standard deviations of the O.D for control mouse
sera at 1/100 dilution. Figure shows mean and standard error of n = 5–6 infected
mice per clone. Groups not connected by the same letter denote pairs that are
signiﬁcantly different (P < 0.05) according to Tukey’s Pairwise analysis.
Fig. 4. IgG2a antibody response and amino acid homology to recombinant MSP-119
antigen from clone AS. Antibody titre shown as black bars and left y-axis was
calculated as the reciprocal of the greatest dilution at which O.D was greater than
the mean plus 2 standard deviations of the O.D for control mouse sera at 1/100
dilution. Figure shows mean and standard error of n = 5–6 infected mice per clone.
Groups not connected by the same letter denote pairs that are signiﬁcantly different
(P < 0.05) according to Tukey’s Pairwise analysis. The black line and right y-axis
show the proportion of amino acid sequence homology to the MSP-119 recombinant
antigen from clone AS.
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which are relevant to binding of host antibodies and/or differential
immunogenicity of AMA-1 variants (as described in Plasmodium
falciparum; (Drew et al., 2012; Kusi et al., 2009)). Thus, we predict
that clones more similar in amino acid sequence to the MSP-119
source clone AS would generate greater antibody titre to
AS-MSP-119, but that amino acid similarity to the AMA-1 source
clone DK would not. A genetic method (linkage group selection)
for identifying loci that encode target antigens of clone-speciﬁc
protective immunity likewise highlighted a greater role for msp-1
(Cheesman et al., 2010; Martinelli et al., 2005) than ama-1
(Pattaradilokrat et al., 2007).
Our results suggest thatMSP-119 amino acid sequence homology
(Cheesman et al., 2009) and overall immune potency of competing
clonesmight be used to predict the role of antibodies in competition
during mixed-clone infections. For example, we would expect a
slow-growing clone to ‘lose’ when in competition with a fast repli-
cating clone with which it shares antigens. Thus, AS should lose to
the antigenically similar but faster replicating AJ (and indeed, it
does; e.g., (Bell et al., 2006)), but not the antigenically dissimilar
CR or ER. Beyond sequence homology, differing immune potency
of clones was the best predictor of variation in titre. This suggests
that AQ but not AJ could affect AS replication via cross-reactivity.
Our results may also shed light on previously unexplained out-
comes of competition among P. chabaudi clones, particularly dur-
ing the chronic phase of infection, when antibody-mediated
immune responses may be most inﬂuential. For example, our re-
sults could reconcile the apparently conﬂicting results of the stud-
ies in immunocompromised mice (lacking T-cells, albeit in
different ways) that set out to investigate within-host competition
in the absence of immune-mediated apparent competition (Barclay
et al., 2008; Raberg et al., 2006). In mixed infection with AS and AJ,
competition was alleviated in immunocompromised mice (Raberg
et al., 2006) whereas competition was not alleviated between AS
and DK (Barclay et al., 2008). We have demonstrated the potential
for clone-transcending responses for AS and AJ but not AS and DK.
This suggests that competition between AS and DK is unlikely to be
immune-mediated so it is perhaps unsurprising that the outcome
of mixed infection was not altered in immunocompromised mice.
Of course, the polymorphisms in MSP-119 and AMA-1 are only a
fraction of the antigenic variation exhibited by malaria parasites.
For example, an extraordinary repertoire of variable surface anti-
gens, encoded for by the VAR gene family, are displayed on P. falci-
parum infected RBC. Such antigenic variation and cross-reactivity
among variants are expected to promote chronic infections (Recker
et al., 2004). A similar gene family (cir genes) has been identiﬁed in
P. chabaudi (Lawton et al., 2012), though for the antigens and time-
scales of our experiments, little role for those variants in driving
the variation among clones in immune response induction is ex-
pected (Fischer et al., 2003). It would be extremely interesting,
though challenging, to determine the potential for immune-medi-
ated competition to be acting through these target antigens. Mos-
quito transmission of P. chabaudi regulates expression of the cir
genes and also modiﬁes host immune responses (Spence et al.,
2013). How immune-mediated apparent competition is affected
by vector-transmitted parasites warrants investigation if we are
to understand the complexities of natural infections. For example,
variation in the number of sporozoites injected by the mosquito
and development through the liver stages to the erythrocytic
stages may impact the magnitude, speciﬁcity and rate of antibody
production.
Understanding immune-mediated competition has important
implications for vaccine design as well as virulence evolution (Mid-
eo, 2009). IgG2a responses to AMA-1 appear largely similar across
clones, suggesting that it has the potential to induce a clone-tran-
scending response. This would be considered desirable for
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immune selection. Recent work by Barclay et al. (2012) has demon-
strated that vaccination with AMA-1 leads to the evolution of more
virulent DK parasites, which achieve higher parasite densities and
are less well controlled by vaccination than the ancestral clone.
Whether all P. chabaudi, and indeed P. falciparum, clones would
respond the same way to clone-transcending immune-selection
remains to be empirically investigated, as does the potential for
immune-mediated competition in vaccinated or non-naïve hosts.4. Disclosure statement
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